Biomarker-driven targeted oral treatment strategy for bladder cancer

被引：0
|
作者：
Morera, Daley S.
Jordan, Andre
Lokeshwar, Vinata B.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1146
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Innovations in Precision Oncology: Biomarker-Driven Approaches for Enhanced Cancer Therapy
    Kargbo, Robert B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (02): : 169 - 170
  • [32] Implementation of Biomarker-Driven Cancer Therapy: Existing Tools and Remaining Gaps
    Bailey, Ann M.
    Mao, Yong
    Zeng, Jia
    Holla, Vijaykumar
    Johnson, Amber
    Brusco, Lauren
    Chen, Ken
    Mendelsohn, John
    Routbort, Mark J.
    Mills, Gordon B.
    Meric-Bernstam, Funda
    DISCOVERY MEDICINE, 2014, 17 (92) : 101 - 114
  • [33] Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients
    van Doorn-Khosrovani, S. B. van Waalwijk
    Pisters-van Roy, A.
    van Saase, L.
    van der Graaff, M.
    Gijzen, J.
    Sleijfer, S.
    Hoes, L. R.
    Henegouwen, J. M. van Berge
    van der Wijngaart, H.
    van der Velden, D. L.
    van Werkhoven, E.
    Retel, V. P.
    van Harten, W. H.
    Huitema, A. D. R.
    Timmers, L.
    Gelderblom, H.
    Verheul, H. M. W.
    Voest, E. E.
    ANNALS OF ONCOLOGY, 2019, 30 (05) : 663 - 665
  • [34] Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas
    Koch, Raphael
    Christie, Amanda L.
    Crombie, Jennifer L.
    Palmer, Adam C.
    Plana, Deborah
    Shigemori, Kay
    Morrow, Sara N.
    Van Scoyk, Alexandria
    Wu, Wenchao
    Brem, Elizabeth A.
    Secrist, J. Paul
    Drew, Lisa
    Schuller, Alwin G.
    Cidado, Justin
    Letai, Anthony
    Weinstock, David M.
    BLOOD, 2019, 133 (06) : 566 - 575
  • [35] Biomarker-driven targeting of NAD metabolism in rhabdomyosarcoma
    Vasquez, Juan C.
    Bhardwaj, Prateek
    Zhao, Sophia
    Noronha, Katelyn
    Lucas, Karlie
    Sundaram, Ranjini
    Heer, Collin
    Morotti, Raffaella
    Spurrier, Josh
    Bindra, Ranjit S.
    CANCER RESEARCH, 2024, 84 (17)
  • [36] Ethical Challenges in Biomarker-Driven Drug Development
    Hey, Spencer Phillips
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (01) : 23 - 25
  • [37] Arguments against the biomarker-driven diagnosis of AD
    Chiu, Helen F. K.
    Brodaty, Henry
    INTERNATIONAL PSYCHOGERIATRICS, 2013, 25 (02) : 177 - 181
  • [38] BIOMARKER-DRIVEN TRIALS IN EARLY DRUG DEVELOPMENT
    Fine, B. M.
    ANNALS OF ONCOLOGY, 2012, 23 : 22 - 22
  • [39] Accumulating evidence from meta-analyses of prognostic studies on oral cancer: towards biomarker-driven patient selection
    Almangush, Alhadi
    Alabi, Rasheed Omobolaji
    Pirinen, Matti
    Maekitie, Antti
    Leivo, Ilmo
    BMC CANCER, 2024, 24 (01)
  • [40] Biomarker-driven precision medicine for hepatocellular carcinoma
    Kodama, Takahiro
    Myojin, Yuta
    Hikita, Hayato
    Sakamori, Ryotaro
    Tatsumi, Tomohide
    Takehara, Tetsuo
    CANCER SCIENCE, 2022, 113
12345